A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Sign up to get notified once we do.
Biktarvy is a prescription drug for treating Human Immunodeficiency Virus (HIV-1) in adults who have never been treated for HIV before or who have suppressed viral loads. It contains a combination of three different drugs that attack different parts of the HIV particles.
Take Biktarvy exactly as directed by your doctor. The usual dosage is one tablet by mouth every day with or without food.
The active ingredients in Biktary are bictegravir, emtricitabine, and tenofovir alafenamide.
Tell your doctor if you are taking any of the following before starting Biktarvy.
Do not take this drug if you are taking dofetilide or rifampin.
Tell your doctor if you have a history of kidney or liver problems before starting this drug.
Stop taking this drug if you develop lactic acidosis symptoms while taking it.
It is not recommended to use other antiretroviral medications while using Biktarvy.
Do not take this drug if you are also infected with the hepatitis B virus.
Common adverse reactions may include: